1. European Medicines Agency.EMA patient registries initiative. Accessed February 15 2019.
2. EMA Cross‐Committee Task Force on Patient Registries.Discussion paper: use of patient disease registries for regulatory purposes – methodological and operational considerations (November 5 2018). Accessed February 15 2019.
3. Registries in European post-marketing surveillance: a retrospective analysis of centrally approved products, 2005-2013
4. Registries supporting new drug applications
5. European Medicines Agency.Patient Registries Workshop 28 October 2016. Observations and recommendations arising from the workshop (February 13 2017). Accessed February 15 2019.